The gut microbiota in thrombosis.

Autor: Khuu MP; Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Johannes Gutenberg-University Mainz, Mainz, Germany., Paeslack N; Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Johannes Gutenberg-University Mainz, Mainz, Germany., Dremova O; Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Johannes Gutenberg-University Mainz, Mainz, Germany., Benakis C; Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany., Kiouptsi K; Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Johannes Gutenberg-University Mainz, Mainz, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz, Germany., Reinhardt C; Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Johannes Gutenberg-University Mainz, Mainz, Germany. christoph.reinhardt@unimedizin-mainz.de.; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz, Germany. christoph.reinhardt@unimedizin-mainz.de.
Jazyk: angličtina
Zdroj: Nature reviews. Cardiology [Nat Rev Cardiol] 2024 Sep 17. Date of Electronic Publication: 2024 Sep 17.
DOI: 10.1038/s41569-024-01070-6
Abstrakt: The gut microbiota has emerged as an environmental risk factor that affects thrombotic phenotypes in several cardiovascular diseases. Evidence includes the identification of marker species by sequencing studies of the gut microbiomes of patients with thrombotic disease, the influence of antithrombotic therapies on gut microbial diversity, and preclinical studies in mouse models of thrombosis that have demonstrated the functional effects of the gut microbiota on vascular inflammatory phenotypes and thrombus formation. In addition to impaired gut barrier function promoting low-grade inflammation, gut microbiota-derived metabolites have been shown to act on vascular cell types and promote thrombus formation. Therefore, these meta-organismal pathways that link the metabolic capacities of gut microorganisms with host immune functions have emerged as potential diagnostic markers and novel drug targets. In this Review, we discuss the link between the gut microbiota, its metabolites and thromboembolic diseases.
(© 2024. Springer Nature Limited.)
Databáze: MEDLINE
Externí odkaz: